Proposed pharma tariffs may spike US drug prices by 12.9%: EY report
The pharmaceutical industry is warning that such tariffs could disrupt supply chains, raise production costs, hurt export competitiveness, and endanger...
The pharmaceutical industry is warning that such tariffs could disrupt supply chains, raise production costs, hurt export competitiveness, and endanger...